GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sysmex Corp (TSE:6869) » Definitions » EV-to-FCF

Sysmex (TSE:6869) EV-to-FCF : 92.16 (As of May. 05, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Sysmex EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Sysmex's Enterprise Value is 円1,648,166 Mil. Sysmex's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was 円17,884 Mil. Therefore, Sysmex's EV-to-FCF for today is 92.16.

The historical rank and industry rank for Sysmex's EV-to-FCF or its related term are showing as below:

TSE:6869' s EV-to-FCF Range Over the Past 10 Years
Min: 31.1   Med: 70.72   Max: 162.69
Current: 92.16

During the past 13 years, the highest EV-to-FCF of Sysmex was 162.69. The lowest was 31.10. And the median was 70.72.

TSE:6869's EV-to-FCF is ranked worse than
84.89% of 364 companies
in the Medical Devices & Instruments industry
Industry Median: 28.38 vs TSE:6869: 92.16

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-05), Sysmex's stock price is 円2660.50. Sysmex's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was 円71.814. Therefore, Sysmex's PE Ratio for today is 37.05.


Sysmex EV-to-FCF Historical Data

The historical data trend for Sysmex's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sysmex EV-to-FCF Chart

Sysmex Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 84.89 60.08 78.75 67.95 66.90

Sysmex Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 150.04 66.90 61.67 59.34 90.75

Competitive Comparison of Sysmex's EV-to-FCF

For the Medical Instruments & Supplies subindustry, Sysmex's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sysmex's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sysmex's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Sysmex's EV-to-FCF falls into.



Sysmex EV-to-FCF Calculation

Sysmex's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=1648166.217/17884
=92.16

Sysmex's current Enterprise Value is 円1,648,166 Mil.
Sysmex's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円17,884 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sysmex  (TSE:6869) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Sysmex's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=2660.50/71.814
=37.05

Sysmex's share price for today is 円2660.50.
Sysmex's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円71.814.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Sysmex EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Sysmex's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Sysmex (TSE:6869) Business Description

Traded in Other Exchanges
Address
1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, JPN, 6510073
Sysmex Corp manufactures and distributes in vitro diagnostic instruments, reagents, and software. The vast majority of the firm's revenue comes from selling tests for human bodily fluids to hospitals and commercial laboratories. Within this industry, the firm specializes in hematology reagents and instruments. Sysmex also sells in vitro diagnostics for applications like urinalysis and hemostasis and provides support and maintenance services for its systems. Over half of the firm's revenue is generated by sales of reagents and services, which are recurring sources of income. Sysmex primarily sells its products to customers in Japan, Europe, the Middle East, and Africa, and the Americas.

Sysmex (TSE:6869) Headlines

No Headlines